CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 107 enrolled
Drug / intervention
Phenazopyridinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02424149
NCT02424149N/ACompleted
CompareCT.gov

Use of Phenazopyridine for Confirmation of Ureteral Patency During Intraoperative Cystoscopy

Hartford Hospital·interventional·Posted Apr 22, 2015·Updated Dec 5, 2016

In Brief

A clinical study evaluating Phenazopyridine for Cystoscopy. Completed, enrolled 107 participants across 1 site.

Detailed Summary

In this prospective, randomized trial subjects will be randomized to receive phenazopyridine or no medication prior to pelvic reconstructive procedures that use cystoscopy to confirm ureteral patency intraoperatively.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystoscopy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 22, 2015
Enrollment StartApr 1, 2015
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 11.2 years ago

Interventions

Phenazopyridinedrug